These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 25289898

  • 1. Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway.
    Bai X, Wang J, Guo Y, Pan J, Yang Q, Zhang M, Li H, Zhang L, Ma J, Shi F, Shu W, Wang Y, Leng J.
    Sci Rep; 2014 Oct 07; 4():6538. PubMed ID: 25289898
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
    Bai X, Yang Q, Shu W, Wang J, Zhang L, Ma J, Xia S, Zhang M, Cheng S, Wang Y, Leng J.
    Mol Med Rep; 2014 May 07; 9(5):1729-36. PubMed ID: 24584670
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
    Bai X, Wang J, Zhang L, Ma J, Zhang H, Xia S, Zhang M, Ma X, Guo Y, Rong R, Cheng S, Shu W, Wang Y, Leng J.
    Int J Oncol; 2013 May 07; 42(5):1833-41. PubMed ID: 23525457
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.
    Zhang M, Zhang H, Cheng S, Zhang D, Xu Y, Bai X, Xia S, Zhang L, Ma J, Du M, Wang Y, Wang J, Chen M, Leng J.
    Tumour Biol; 2014 Jul 07; 35(7):7135-45. PubMed ID: 24760275
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 induced β1-integrin expression in NSCLC and promoted cell invasion via the EP1/MAPK/E2F-1/FoxC2 signal pathway.
    Pan J, Yang Q, Shao J, Zhang L, Ma J, Wang Y, Jiang BH, Leng J, Bai X.
    Sci Rep; 2016 Sep 22; 6():33823. PubMed ID: 27654511
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of PKC/MEK pathway suppresses β1-integrin and mitigates breast cancer cells proliferation.
    El-Ashmawy NE, El-Zamarany EA, Khedr NF, Selim HM, Khedr EG.
    Toxicol Rep; 2021 Sep 22; 8():1530-1537. PubMed ID: 34408972
    [Abstract] [Full Text] [Related]

  • 7. Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells.
    Liu JF, Fong YC, Chang CS, Huang CY, Chen HT, Yang WH, Hsu CJ, Jeng LB, Chen CY, Tang CH.
    Mol Cancer; 2010 Feb 23; 9():43. PubMed ID: 20178602
    [Abstract] [Full Text] [Related]

  • 8. PGE2 upregulates renin through E-prostanoid receptor 1 via PKC/cAMP/CREB pathway in M-1 cells.
    Gonzalez AA, Salinas-Parra N, Leach D, Navar LG, Prieto MC.
    Am J Physiol Renal Physiol; 2017 Oct 01; 313(4):F1038-F1049. PubMed ID: 28701311
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S, Ma J, Bai X, Zhang H, Cheng S, Zhang M, Zhang L, Du M, Wang Y, Li H, Rong R, Shi F, Yang Q, Leng J.
    Oncol Rep; 2014 Oct 01; 32(4):1521-30. PubMed ID: 25109834
    [Abstract] [Full Text] [Related]

  • 10. Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression.
    Zhang H, Cheng S, Zhang M, Ma X, Zhang L, Wang Y, Rong R, Ma J, Xia S, Du M, Shi F, Wang J, Yang Q, Bai X, Leng J.
    Int J Oncol; 2014 Mar 01; 44(3):769-80. PubMed ID: 24378923
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
    Bai XM, Jiang H, Ding JX, Peng T, Ma J, Wang YH, Zhang L, Zhang H, Leng J.
    Life Sci; 2010 Jan 30; 86(5-6):214-23. PubMed ID: 20035770
    [Abstract] [Full Text] [Related]

  • 12. Prostaglandin E2 EP1 receptor enhances TGF-β1-induced mesangial cell injury.
    Chen X, Jiang D, Wang J, Chen X, Xu X, Xi P, Fan Y, Zhang X, Guan Y.
    Int J Mol Med; 2015 Jan 30; 35(1):285-93. PubMed ID: 25352206
    [Abstract] [Full Text] [Related]

  • 13. EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth.
    Niu JC, Ma N, Liu W, Wang PJ.
    Bosn J Basic Med Sci; 2019 Aug 20; 19(3):265-273. PubMed ID: 30995899
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors.
    Nasrallah R, Hassouneh R, Zimpelmann J, Karam AJ, Thibodeau JF, Burger D, Burns KD, Kennedy CR, Hébert RL.
    Lab Invest; 2015 Sep 20; 95(9):1044-55. PubMed ID: 26121313
    [Abstract] [Full Text] [Related]

  • 15. Effect of prostaglandin E2 on multidrug resistance transporters in human placental cells.
    Mason CW, Lee GT, Dong Y, Zhou H, He L, Weiner CP.
    Drug Metab Dispos; 2014 Dec 20; 42(12):2077-86. PubMed ID: 25261564
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C, Michalopoulos GK, Wu T.
    J Cell Physiol; 2006 Apr 20; 207(1):261-70. PubMed ID: 16331686
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma.
    Yang H, Wang M, Sun H, Zhu S, Jin J.
    Pharmacology; 2019 Apr 20; 104(5-6):267-275. PubMed ID: 31434088
    [Abstract] [Full Text] [Related]

  • 19. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D, Fu L, Sun H, Guo L, DuBois RN.
    Gastroenterology; 2015 Dec 20; 149(7):1884-1895.e4. PubMed ID: 26261008
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.